ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,048.42
      -0.46%
      US Tech 100
      17,168.35
      0.63%
      Dow Jones
      38,085.80
      -0.98%
      Brent Oil
      88.105
      -0.05%
      Bitcoin
      64,397.18
      -0.14%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ
      6. AVEO Pharmaceuticals Inc (AVEO)

      7. AVEO Pharmaceuticals Inc (AVEO) News

      AVEO

      AVEO Pharmaceuticals (AVEO)

      		Date:
      Sort by:
       Showing the most relevant articles for your search:NASDAQ:AVEO
      DateTimeSourceHeadlineSymbolCompany
      12:52PMiHub NewswireFeaturedCannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA
      03/28/20243:22PMGlobeNewswire Inc.CORRECTION – AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory CommitteeNASDAQ:AVEOAVEO Pharmaceuticals Inc
      03/25/20248:10AMGlobeNewswire Inc.AVEO Oncology Announces Appointment of Chief Medical Officer and Formation of Scientific Advisory CommitteeNASDAQ:AVEOAVEO Pharmaceuticals Inc
      02/06/20248:10AMGlobeNewswire Inc.AVEO Oncology Announces Publication of Long-Term Survival in Patients With Relapsed/Refractory Advanced Renal Cell Carcinoma Treated With Tivozanib: Analysis of the Phase III TIVO-3 Trial in The OncologistNASDAQ:AVEOAVEO Pharmaceuticals Inc
      01/16/20247:30AMGlobeNewswire Inc.AVEO Oncology Enrolls First Patient in Pivotal FIERCE-HN Clinical Trial to Evaluate Ficlatuzumab in Combination with ERBITUX® (cetuximab) in Patients with HPV-negative Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma (R/M HNSCC)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      01/30/20234:08PMEdgar (US Regulatory)Termination of Registration of a Class of Security Under Section 12(g) (15-12g)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      01/24/20236:07AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      01/24/20236:07AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      01/24/20236:07AMEdgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      01/19/20235:20PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      01/19/20235:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      01/19/20235:17PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      01/19/20235:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      01/19/20235:16PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      01/19/20235:05PMEdgar (US Regulatory)Notification Filed by National Security Exchange to Report the Removal From Listing and Registration of Matured, Redeemed or Retired Securities Initial Filing Amendments (25-nse)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      01/19/20234:47PMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      01/19/20234:46PMEdgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      01/19/20234:44PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      01/19/20234:43PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      01/19/20234:42PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      01/19/20234:40PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      01/19/20234:40PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      01/19/20234:38PMEdgar (US Regulatory)Post-effective Amendment to an S-8 Filing (s-8 Pos)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      01/19/20234:35PMGlobeNewswire Inc.LG Chem Completes Acquisition of AVEO OncologyNASDAQ:AVEOAVEO Pharmaceuticals Inc
      01/18/20238:41AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      01/05/20234:59PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      12/23/20224:02PMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      12/22/20224:47PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      12/02/20229:07AMEdgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:AVEOAVEO Pharmaceuticals Inc
      12/02/20229:05AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:AVEOAVEO Pharmaceuticals Inc
       Showing the most relevant articles for your search:NASDAQ:AVEO